Hepatic fibrosis

Common Name(s)

Hepatic fibrosis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatic fibrosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatic fibrosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hepatic fibrosis" returned 430 free, full-text research articles on human participants. First 3 results:

Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
 

Author(s): Bing Zhou, Li Ling, Feng Zhang, Tong-Yan Liu, Hong Zhou, Xiao-Hong Qi, Qi Chen, Yue-Hua Li, Yu-Ming Kang, Guo-Qing Zhu

Journal: Cell. Physiol. Biochem.. 2018 ;48(1):227-236.

 

Fibronectin type III domain-containing 5 (FNDC5) protein is involved in the beneficial effects of exercise on metabolism. FNDC5 attenuates hepatic steatosis induced by high fat diet (HFD). Here, we examined the effects of FNDC5 on liver fibrosis and underline mechanisms.

Last Updated: 31 Dec 1969

Go To URL
Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats.
 

Author(s): Huimin Liu, Zhenfang Zhang, Huangwanyin Hu, Congen Zhang, Ming Niu, Ruishen Li, Jiabo Wang, Zhaofang Bai, Xiaohe Xiao

Journal:

 

Liuweiwuling tablets (LWWL) are an herbal product that exerts remarkable effects on liver protection and aminotransferase levels, and they have been approved by the Chinese State Food and Drug Administration (CFDA). Clinical studies have found that LWWL can inhibit collagen production ...

Last Updated: 31 Dec 1969

Go To URL
Interleukin (IL)-13, Prostaglandin E2 (PGE2), and Prostacyclin 2 (PGI2) Activate Hepatic Stellate Cells via Protein kinase C (PKC) Pathway in Hepatic Fibrosis.
 

Author(s): Guode Sui, Guang Cheng, Junjun Yuan, Xuena Hou, Xiaochen Kong, Haitao Niu

Journal:

 

BACKGROUND Protein kinase C (PKC), interleukin (IL)-13, prostaglandin E2 (PGE2), and prostacyclin 2 (PGI2) can all play crucial roles in pulmonary fibrosis. However, their functions remain unclear in hepatic fibrosis mediated by hepatic stellate cells (HSCs), which has been demonstrated ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hepatic fibrosis" returned 62 free, full-text review articles on human participants. First 3 results:

PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review).
 

Author(s): Hua-Zhong Ying, Qin Chen, Wen-You Zhang, Huan-Huan Zhang, Yue Ma, Song-Zhao Zhang, Jie Fang, Chen-Huan Yu

Journal: Mol Med Rep. 2017 Dec;16(6):7879-7889.

 

The platelet‑derived growth factor (PDFG) signaling pathway exerts persistent activation in response to a variety of stimuli and facilitates the progression of hepatic fibrosis. Since this pathway modulates a broad spectrum of cellular processes, including cell growth, differentiation, ...

Last Updated: 31 Dec 1969

Go To URL
Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.
 

Author(s): Jeanne M Horowitz, Sudhakar K Venkatesh, Richard L Ehman, Kartik Jhaveri, Patrick Kamath, Michael A Ohliger, Anthony E Samir, Alvin C Silva, Bachir Taouli, Michael S Torbenson, Michael L Wells, Benjamin Yeh, Frank H Miller

Journal: Abdom Radiol (NY). 2017 Aug;42(8):2037-2053.

 

Hepatic fibrosis is potentially reversible; however early diagnosis is necessary for treatment in order to halt progression to cirrhosis and development of complications including portal hypertension and hepatocellular carcinoma. Morphologic signs of cirrhosis on ultrasound (US), ...

Last Updated: 31 Dec 1969

Go To URL
Acoustic Radiation Force Impulse (ARFI) Elastography for non‑invasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis.
 

Author(s): Xiangdong Hu, Lanyan Qiu, Dong Liu, Linxue Qian

Journal: Med Ultrason. 2017 Jan;19(1):23-31.

 

The purpose of the study was to assess the effect of Acoustic Radiation Force Impulse (ARFI) elastography in the diagnosis of liver fibrosis in chronic hepatitis B and C patients through Meta-analysis.

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
 

Status: Recruiting

Condition Summary: Chronic Hepatitis B; Hepatic Fibrosis; Fatty Liver

 

Last Updated: 23 Apr 2018

Go to URL
A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers
 

Status: Recruiting

Condition Summary: Hepatitis B; Liver Fibrosis

 

Last Updated: 25 Jun 2018

Go to URL
A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C
 

Status: Recruiting

Condition Summary: Hepatic Cirrhosis; Liver Fibrosis

 

Last Updated: 8 Aug 2018

Go to URL